首页> 外文OA文献 >Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models

【2h】

Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models

机译：使用生理基于物理基础药代动力学模型对肝脏消除药物肝脏消除药物对药物杂草型幅度的影响的定量分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Takashi Yoshikado; Kazuya Maeda; Hiroyuki Kusuhara; Ken-ichi Furihata; Yuichi Sugiyama;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Use of a Physiologically Based Pharmacokinetic Model for Quantitative Prediction of Drug-Drug Interactions via CYP3A4 and Estimation of the Intestinal Availability of CYP3A4 Substrates [J] . Mano Yoko, Sugiyama Yuichi, Ito Kiyomi Journal of pharmaceutical sciences. . 2015,第9期

机译：基于生理的药代动力学模型对通过CYP3A4进行的药物相互作用的定量预测和对CYP3A4底物肠道利用率的估计
2. Prediction of time-dependent CYP3A4 drug-drug interactions by physiologically based pharmacokinetic modelling: impact of inactivation parameters and enzyme turnover. [J] . Rowland Yeo K, Walsky RL, Jamei M, European journal of pharmaceutical sciences . 2011,第3期

机译：通过基于生理学的药代动力学模型预测时间依赖性CYP3A4药物-药物相互作用：失活参数和酶更新的影响。
3. Use of Three-Compartment Physiologically Based Pharmacokinetic Modeling to Predict Hepatic Blood Levels of Fluvoxamine Relevant for Drug-Drug Interactions [J] . Iga Katsumi Journal of pharmaceutical sciences. . 2015,第4期

机译：基于生理的三室药代动力学模型预测与药物相互作用有关的氟伏沙明的肝血水平
4. Pharmacokinetic simulation for prediction of drug-drug interactions based on agent based modeling [C] . Sathien Hunta, Panchit Longpradit International Conference on Digital Arts, Media and Technology . 2018

机译：基于代理建模的药物动力学模拟预测药物相互作用
5. In Vitro-In Vivo Assessment of Repaglinide Metabolism and Drug-Drug Interactions: Towards a Physiologically-Based Pharmacokinetic Model [D] . Thule S?ll, Carolina Maria. 2013

机译：瑞格列奈代谢和药物-药物相互作用的体外评估：建立基于生理学的药代动力学模型
6. When Does the Rate-Determining Step in the Hepatic Clearance of a Drug Switch from Sinusoidal Uptake to All Hepatobiliary Clearances? Implications for Predicting Drug-Drug Interactions [O] . Gabriela I. Patilea-Vrana, Jashvant D. Unadkat -1

机译：药物肝清除率的决定性步骤何时从正弦吸收转变为所有肝胆清除率？预测药物相互作用的意义
7. Assessing OATP1B1- and OATP1B3-Mediated Drug-Drug Interaction Potential of Vemurafenib Using R-Value and Physiologically-Based Pharmacokinetic Models [O] . Ruhul Kayesh, Taleah Farasyn, Alexandra Crowe, 2021

机译：评估Vemurafenib的oatp1b1-和oatp1b3介导的vemureafenib的药物 - 药物相互作用潜力使用r值和基于生理学的药代动力学模型

Quantitative Analyses of the Influence of Parameters Governing Rate-Determining Process of Hepatic Elimination of Drugs on the Magnitudes of Drug-Drug Interactions via Hepatic OATPs and CYP3A Using Physiologically Based Pharmacokinetic Models

著录项

引文网络

相似文献

相关主题

期刊订阅